Search results for: Innovation Policy Prize

What Drives Variations in Relative Effectiveness Across Countries?

31 May 2016

…between populations and healthcare systems. Relative effectiveness is a key topic within health policy. In Europe, this is due to the need for early information to guide reimbursement and funding…

The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics

5 July 2016

…proposes a broader framework for considering the value contribution of complementary diagnostics and provides policy recommendations to support the implementation of this comprehensive framework for assessing their potential value contribution….

Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA

17 January 2024

…whether there is a risk of green-washing practices. Finally, she stressed that patients need to be at the centre of policy designs around sustainability. Importantly, policies and healthcare solutions should…

Presentation at the NHS Global Health Volunteering Group Meeting: “The Value of International Volunteering and Placements to the NHS”

…economic value for the NHS from international volunteering is mainly derived from diffusion of innovation in management and service delivery. The private value for the volunteers comes from increased productivity…

Opportunities for Utilising ‘Real World Data’ in South Korea

20 October 2017

…local government and public institutions, or research organisations with an academic or public policy purpose. Opportunities for data linkage are limited, and the patient consent models that guide data use…

Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help? A Summary of a Symposium held at HTAi Rome 2017

31 October 2017

…an effective treatment; the innovation value of creating a new mode of action; the ability to preserve the safety of procedures that rely on the use of antibiotics (enablement value);…

OHE at ISPOR’s 20th Annual European Congress: Presentations

…Cancer’ special issue of the Journal of Cancer Policy. Is willingness to pay higher for cancer prevention and treatment? from Office of Health Economics   In another poster, Koonal examined…

Routine Funding in the UK NHS of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure

18 December 2017

This report analyses patient access in the UK to new medicines authorised via the centralised procedure between 2011 and 2016. The centralised procedure was created in 1995 to facilitate access…

OHE’s In-house Publications Are Now Indexed by RePEc

8 May 2018

OHE is on RePEc: find publications from the Office of Health Economics in Research Papers in Economics. For many years, we’ve been publishing our work – free to read – on…